Table 2. Health outcomes and results from cost-effectiveness analysis.
| Strategy | Cost (¥) | LEs (years) | QALYs | Incr LEs (years) | Incr QALYs | ICER (C/QALY) |
|---|---|---|---|---|---|---|
| (95% CI) | (95% CI) | (95% CI) | (95% CI) | (95% CI) | (95% CI) | |
| 30-year | ||||||
| Usual care | 79848 (50543,107539) | 24.92 (16.64−28.77) | 15.14 (10.70−18.01) | |||
| Intervention | 74510 (50948,95736) | 26.36 (18.41−29.15) | 15.88 (11.78−18.26) | 1.44 | 0.74 | −8211 (−24483,3366) |
| Lifetime | ||||||
| Usual care | 88241 (61578,151126) | 27.60 (19.97−46.74) | 15.85 (11.33−22.43) | |||
| Intervention | 86294 (63000,141427) | 30.75 (21.73−49.15) | 17.01 (12.35−23.12) | 3.14 | 1.16 | −1652 (−76257,1755) |
CDV, cardiovascular disease; LE, life expectancy; CI, confidence interval; Incr, incremental; QALY, quality-adjusted life-year; ICER, incremental cost-effectiveness ratio.